xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Oct 5, 2020
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Referral to non-invasive nuclear ischemia test as part of clinical care
- • Suspected coronary artery disease based on clinical symptoms
- • Informed Consent as documented by signature
- Exclusion Criteria:
- • Pregnancy
- • Allergy against adenosine
- • Allergy against iodinated contrast medium
- • Recent myocardial infarction (\<1 month)
- • Previous history of coronary revascularization
- • Severe asthma
- • Thyroid hyperfunction
- • atrioventricular block (AV) Block \> I grade
- • Arrhythmic cardiopathy
- • Weight \>101 Kg.
- • Acute or chronic renal impairment defined as Serum-Creatinine: above 1.5x upper limit of normal (ULN) and/or glomerular filtration rate (GFR) \< 30 ml/min
- • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- • Participation in another study with investigational drug within the 30 days preceding and during the present study,
- • Enrolment of the investigator, his/her family members, employees and other dependent persons,
- • Claustrophobia
- • Intake of caffeine \<24 Hours before the first day of examination
- • Enrolment into another study using ionizing radiation within the previous 12 months.
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Federico Caobelli, Dr. med.
Principal Investigator
Clinic of Radiology & Nuclear Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials